Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yuta Okumura
Observed names:
Y. Okumura,
YUTA OKUMURA
Institution:
National Hospital Organization Kyushu Cancer Center
Observed institutions:
Kyushu University,
National Hospital Organization Kyushu Cancer Center,
Kyushu University Hospital,
Kyushu University Beppu Hospital
ORCID:
0000-0002-7825-8373
Observed ORCID:
0000-0002-7825-8373
OpenAlex ID:
A5059227226
Dedifferentiation process driven by TGF-beta signaling enhances stem cell properties in human colorectal cancer
2018
·
Michitaka Nakano
, Yoshikane Kikushige
, et al.
·
Oncogene
·
125
PD ‐1+ TIM ‐3+ T cells in malignant ascites predict prognosis of gastrointestinal cancer
2018
·
Michitaka Nakano
, Mamoru Ito
, et al.
·
Cancer Science
·
49
PDF
Bi-cytopenia possibly induced by anti-PD-1 antibody for primary malignant melanoma of the esophagus: A case report
2016
·
Kyoko Inadomi
, Hozumi Kumagai
, et al.
·
Medicine
·
40
Methylation of drug resistance‐related genes in chemotherapy‐sensitive Epstein–Barr virus‐associated gastric cancer
2019
·
Hirofumi Ohmura
, Mamoru Ito
, et al.
·
FEBS Open Bio
·
27
PDF
Pancreatic acinar cell carcinoma presenting with panniculitis, successfully treated with FOLFIRINOX: A case report
2017
·
Tomoyasu Yoshihiro
, Kenta Nio
, et al.
·
Molecular and Clinical Oncology
·
26
PDF
Liquid biopsy for breast cancer and other solid tumors: a review of recent advances
2024
·
Hirofumi Ohmura
, Fumiyasu Hanamura
, et al.
·
Breast Cancer
·
16
Clinical questions and good practice statements of clinical practice guidelines for management of kidney injury during anticancer drug therapy 2022
2023
·
Motoko Yanagita
, Satoru Muto
, et al.
·
Clinical and Experimental Nephrology
·
16
PDF
Survival in Older Japanese Adults With Advanced Cancer Before and After Implementation of a Geriatric Oncology Service
2023
·
Tomohiro F. Nishijima
, Mototsugu Shimokawa
, et al.
·
JCO Oncology Practice
·
16
Programmed death-ligand 1 expression is associated with fibrosarcomatous transformation of dermatofibrosarcoma protuberans
2017
·
Kenji Tsuchihashi
, Hitoshi Kusaba
, et al.
·
Molecular and Clinical Oncology
·
16
PDF
Clinical benefit of treatment after trastuzumab emtansine for HER2-positive metastatic breast cancer: a real-world multi-centre cohort study in Japan (WJOG12519B)
2021
·
Takamichi Yokoe
, Sasagu Kurozumi
, et al.
·
Breast Cancer
·
15
PDF
Chapter 3: Management of kidney injury caused by cancer drug therapy, from clinical practice guidelines for the management of kidney injury during anticancer drug therapy 2022
2023
·
Yuichi Ando
, Hiroyuki Nishiyama
, et al.
·
International Journal of Clinical Oncology
·
12
Successful combination chemotherapy for metastatic inflammatory myofibroblastic tumor: A case report
2015
·
KYOKO INADOMI
, HOZUMI KUMAGAI
, et al.
·
Oncology Letters
·
12
PDF
Epithelial‐mesenchymal transition is activated in CD 44‐positive malignant ascites tumor cells of gastrointestinal cancer
2018
·
Michitaka Nakano
, Mamoru Ito
, et al.
·
Cancer Science
·
10
PDF
Intraluminal superior vena cava metastasis from adenosquamous carcinoma of the duodenum: A case report
2015
·
KOTOE TAKAYOSHI
, HIROSHI ARIYAMA
, et al.
·
Oncology Letters
·
9
PDF
Therapeutic use of granulocyte colony-stimulating factor (G-CSF) in patients with febrile neutropenia: a comprehensive systematic review for clinical practice guidelines for the use of G-CSF 2022 from the Japan Society of Clinical Oncology
2024
·
Kenji Tsuchihashi
, Mamoru Ito
, et al.
·
International Journal of Clinical Oncology
·
8
Dynamic Changes in Peripheral Systemic Immunity Markers During Chemotherapy in HER2-negative Advanced Breast Cancer
2023
·
TAKAAKI MASUDA
, HIROAKI UEO
, et al.
·
Cancer Genomics & Proteomics
·
6
PDF
PRABITAS study design: a pragmatic, randomized phase III trial of bi-weekly versus conventional trifluridine/tipiracil plus bevacizumab for metastatic colorectal cancer
2024
·
T. Sakakida
, T. Masuishi
, et al.
·
ESMO Gastrointestinal Oncology
·
5
PDF
A multicentre retrospective study comparing site-specific treatment with empiric treatment for unfavourable subset of cancer of unknown primary site
2022
·
Kazuo Nishikawa
, Shuichi Hironaka
, et al.
·
Japanese Journal of Clinical Oncology
·
5
A phase II study of intrapatient dose escalation of biweekly trifluridine/tipiracil plus bevacizumab for colorectal cancer (E-BiTS study)
2025
·
M. Wakabayashi
, H. Taniguchi
, et al.
·
ESMO Open
·
4
PDF
Spontaneous Regression of Metachronous Intra-Abdominal Desmoid Tumor in a Patient with Familial Adenomatous Polyposis
2022
·
Kenji Tsuchihashi
, Kyoko Yamaguchi
, et al.
·
Case Reports in Oncology
·
3
Thrombocytopenia Caused by Dexamethasone in a Patient with Colorectal Cancer
2020
·
Ryosuke Taguchi
, Kenji Tsuchihashi
, et al.
·
Internal Medicine
·
3
PDF
Abstract 1520: Plasticity of CD44+ colorectal cancer stem cells depends on TGF-beta-induced epithelial mesenchymal transition (EMT): evidences from ex vivo culture system
2015
·
Michitaka Nakano
, Hioshi Ariyama
, et al.
·
Cancer Research
·
3
Efficacy and Safety of an Increased-dose of Dexamethasone in Patients Receiving Fosaprepitant Chemotherapy in Japan
2014
·
Hozumi Kumagai
, Hitoshi Kusaba
, et al.
·
Asian Pacific Journal of Cancer Prevention
·
3
PDF
14-day versus 28-day trifluridine–tipiracil plus bevacizumab for refractory metastatic colorectal cancer (PRABITAS): a pragmatic, multicentre, open-label, randomised, phase 3, non-inferiority trial in Japan
2026
·
Tomoki Sakakida
, Hiroya Taniguchi
, et al.
·
The Lancet
·
2
Frailty assessed by a 10-item index from comprehensive geriatric assessment (FI-CGA-10) versus oncologist-assessed performance status (PS) in older adults with gastrointestinal (GI) cancer.
2025
·
Kohei Arimizu
, Yota Kusumoto
, et al.
·
Journal of Clinical Oncology
·
2
PDF
Show more works
View as search
Works count:
45
Citation count:
446
H-index:
12
I10-index:
13
Year
Topic
Type